Published in Behav Brain Res on May 01, 2000
Smaller hippocampal volume predicts pathologic vulnerability to psychological trauma. Nat Neurosci (2002) 5.45
Alcohol: effects on neurobehavioral functions and the brain. Neuropsychol Rev (2007) 2.20
Decreased volume of the brain reward system in alcoholism. Biol Psychiatry (2008) 2.15
Effects of alcohol and combined marijuana and alcohol use during adolescence on hippocampal volume and asymmetry. Neurotoxicol Teratol (2006) 2.01
Decreased hippocampal N-acetylaspartate in the absence of atrophy in posttraumatic stress disorder. Biol Psychiatry (2001) 1.49
Psychophysiological correlates of aggression and violence: an integrative review. Philos Trans R Soc Lond B Biol Sci (2008) 1.16
Distinct cell proliferation events during abstinence after alcohol dependence: microglia proliferation precedes neurogenesis. Neurobiol Dis (2008) 1.16
Roles of neural stem cells and adult neurogenesis in adolescent alcohol use disorders. Alcohol (2010) 1.15
Chronic cigarette smoking modulates injury and short-term recovery of the medial temporal lobe in alcoholics. Psychiatry Res (2008) 1.11
Working and episodic memory in HIV infection, alcoholism, and their comorbidity: baseline and 1-year follow-up examinations. Alcohol Clin Exp Res (2009) 1.08
Hippocampal volume differences in Gulf War veterans with current versus lifetime posttraumatic stress disorder symptoms. Biol Psychiatry (2010) 1.01
Neurodevelopmental marker for limbic maldevelopment in antisocial personality disorder and psychopathy. Br J Psychiatry (2010) 1.00
Attention, learning, and memory in posttraumatic stress disorder. J Trauma Stress (2004) 0.94
Genetic influences in emotional dysfunction and alcoholism-related brain damage. Neuropsychiatr Dis Treat (2005) 0.94
Stress-response pathways are altered in the hippocampus of chronic alcoholics. Alcohol (2013) 0.91
Structural and functional modifications in glutamateric synapses following prolonged ethanol exposure. Alcohol Clin Exp Res (2006) 0.90
Biological studies on alcohol-induced neuronal damage. Psychiatry Investig (2008) 0.85
Association of depressive symptoms with hippocampal volume in 1936 adults. Neuropsychopharmacology (2013) 0.85
Alcohol and adult hippocampal neurogenesis: promiscuous drug, wanton effects. Prog Neuropsychopharmacol Biol Psychiatry (2014) 0.83
Axonal tract tracing for delineating interacting brain regions: implications for Alzheimer's disease-associated memory. Future Neurol (2014) 0.82
Differences in regional cerebral blood flow response to a 5HT3 antagonist in early- and late-onset cocaine-dependent subjects. Addict Biol (2012) 0.79
Genetic, psychosocial and clinical factors associated with hippocampal volume in the general population. Transl Psychiatry (2014) 0.78
Ethanol treatment of lymphoblastoid cell lines from alcoholics and non-alcoholics causes many subtle changes in gene expression. Alcohol (2014) 0.77
Dissociated Accumbens and Hippocampal Structural Abnormalities across Obesity and Alcohol Dependence. Int J Neuropsychopharmacol (2016) 0.76
Neurological and psychiatric diseases and their unique cognitive profiles: implications for nursing practice and research. J Neurosci Nurs (2013) 0.76
Relative brain signature: a population-based feature extraction procedure to identify functional biomarkers in the brain of alcoholics. Brain Behav (2015) 0.75
Decreased hippocampal translocator protein (18 kDa) expression in alcohol dependence: a [(11)C]PBR28 PET study. Transl Psychiatry (2017) 0.75
Anosognosia for Memory Impairment in Addiction: Insights from Neuroimaging and Neuropsychological Assessment of Metamemory. Neuropsychol Rev (2016) 0.75
Gender dimorphism of brain reward system volumes in alcoholism. Psychiatry Res (2017) 0.75
Alcohol's Effects on the Brain: Neuroimaging Results in Humans and Animal Models. Alcohol Res (2017) 0.75
Problematic alcohol use and reduced hippocampal volume: a meta-analytic review. Psychol Med (2017) 0.75
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
MR volumetric analysis of the human entorhinal, perirhinal, and temporopolar cortices. AJNR Am J Neuroradiol (1998) 6.13
Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ (2001) 5.40
Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study. Neurology (2001) 3.56
Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology (2000) 3.39
A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD. Neurology (2001) 3.25
Imaging of soft-tissue sarcomas with indium-111-labeled monoclonal antimyosin Fab fragments. J Nucl Med (1990) 2.80
Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology (2000) 2.43
APOE and Alzheimer disease: a major gene with semi-dominant inheritance. Mol Psychiatry (2011) 2.31
Education and dementia: what lies behind the association? Neurology (2007) 2.26
Hippocampal volumes in Alzheimer's disease, Parkinson's disease with and without dementia, and in vascular dementia: An MRI study. Neurology (1996) 2.23
Volumes of hippocampus, amygdala and frontal lobes in the MRI-based diagnosis of early Alzheimer's disease: correlation with memory functions. J Neural Transm Park Dis Dement Sect (1995) 2.20
Neuronal responses to magnetic stimulation reveal cortical reactivity and connectivity. Neuroreport (1997) 2.13
Detection of grey matter loss in mild Alzheimer's disease with voxel based morphometry. J Neurol Neurosurg Psychiatry (2002) 2.12
Maternal smoking during pregnancy and risk of criminal behavior among adult male offspring in the Northern Finland 1966 Birth Cohort. Am J Psychiatry (1999) 1.85
Serum cholesterol changes after midlife and late-life cognition: twenty-one-year follow-up study. Neurology (2007) 1.81
A voxel based morphometry study on mild cognitive impairment. J Neurol Neurosurg Psychiatry (2005) 1.79
Hippocampal and entorhinal cortex atrophy in frontotemporal dementia and Alzheimer's disease. Neurology (1999) 1.78
Quantitative MRI of the hippocampus and amygdala in severe depression. Psychol Med (2000) 1.77
Prognosis with dementia in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology (2000) 1.76
Prevalence of mild cognitive impairment: a population-based study in elderly subjects. Acta Neurol Scand (2002) 1.75
Seasonal variation in suicide occurrence in Finland. Acta Psychiatr Scand (1998) 1.73
Homocysteine and holotranscobalamin and the risk of Alzheimer disease: a longitudinal study. Neurology (2010) 1.67
Contrast agents and cerebral hemodynamics. Magn Reson Med (1991) 1.55
Volumes of the entorhinal and perirhinal cortices in Alzheimer's disease. Neurobiol Aging (1998) 1.53
Structural correlates of early and late onset Alzheimer's disease: voxel based morphometric study. J Neurol Neurosurg Psychiatry (2005) 1.52
Influence of age, disease onset and ApoE4 on visual medial temporal lobe atrophy cut-offs. J Intern Med (2013) 1.52
Comparative MR analysis of the entorhinal cortex and hippocampus in diagnosing Alzheimer disease. AJNR Am J Neuroradiol (1999) 1.48
Specific changes in somatosensory evoked magnetic fields during recovery from sensorimotor stroke. Ann Neurol (2000) 1.48
The significance of medial temporal lobe atrophy: a postmortem MRI study in the very old. Neurology (2007) 1.46
Association of metabolic syndrome with Alzheimer disease: a population-based study. Neurology (2006) 1.45
Serum testosterone levels in males with Alzheimer's disease. J Neuroendocrinol (2004) 1.43
MRI of the hippocampus in Alzheimer's disease: sensitivity, specificity, and analysis of the incorrectly classified subjects. Neurobiol Aging (1998) 1.39
Cognitive function in an elderly population with persistent impaired glucose tolerance. Diabetes Care (1998) 1.39
PET amyloid ligand [11C]PIB uptake and cerebrospinal fluid beta-amyloid in mild cognitive impairment. Dement Geriatr Cogn Disord (2008) 1.39
The level of cerebrospinal fluid tau correlates with neurofibrillary tangles in Alzheimer's disease. Neuroreport (1997) 1.38
CSF biomarkers for Alzheimer disease correlate with cortical brain biopsy findings. Neurology (2012) 1.35
Metabolome in progression to Alzheimer's disease. Transl Psychiatry (2011) 1.33
Variable agreement between visual rating scales for white matter hyperintensities on MRI. Comparison of 13 rating scales in a poststroke cohort. Stroke (1997) 1.33
Verbal fluency activates the left medial temporal lobe: a functional magnetic resonance imaging study. Ann Neurol (2000) 1.32
Distribution of cortical activation during visuospatial n-back tasks as revealed by functional magnetic resonance imaging. Cereb Cortex (1998) 1.32
APOE-epsilon4 is associated with less frontal and more medial temporal lobe atrophy in AD. Neurology (1999) 1.30
Whole-exome sequencing and imaging genetics identify functional variants for rate of change in hippocampal volume in mild cognitive impairment. Mol Psychiatry (2013) 1.30
Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease: relation to apolipoprotein E polymorphism. Neurology (1996) 1.29
Face-selective processing in human extrastriate cortex around 120 ms after stimulus onset revealed by magneto- and electroencephalography. Neurosci Lett (1998) 1.29
Susceptibility contrast imaging of cerebral blood volume: human experience. Magn Reson Med (1991) 1.26
Hippocampus in Alzheimer's disease: a 3-year follow-up MRI study. Biol Psychiatry (2000) 1.26
Diagnostic accuracy of Alzheimer's disease: a neuropathological study. Acta Neuropathol (1996) 1.26
Delirium among elderly persons admitted to a psychiatric hospital: clinical course during the acute stage and one-year follow-up. Acta Psychiatr Scand (1989) 1.25
Volumes of hippocampus, amygdala and frontal lobe in Alzheimer patients with different apolipoprotein E genotypes. Neuroscience (1995) 1.25
Genome-wide association with MRI atrophy measures as a quantitative trait locus for Alzheimer's disease. Mol Psychiatry (2010) 1.24
Association between low activity serotonin transporter promoter genotype and early onset alcoholism with habitual impulsive violent behavior. Mol Psychiatry (1999) 1.24
Slowing of EEG in Parkinson's disease. Electroencephalogr Clin Neurophysiol (1991) 1.22
Frontal lobe white matter hyperintensities and neurofibrillary pathology in the oldest old. Neurology (2010) 1.22
Poststroke depression and lesion location revisited. J Neuropsychiatry Clin Neurosci (2004) 1.21
Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease. Mol Psychiatry (2012) 1.20
Familial aggregation of Alzheimer's disease and related disorders: a collaborative re-analysis of case-control studies. Int J Epidemiol (1991) 1.20
Mental disorders and homicidal behavior in Finland. Arch Gen Psychiatry (1996) 1.17
Spatiotemporal activity of a cortical network for processing visual motion revealed by MEG and fMRI. J Neurophysiol (1999) 1.17
Beta-amyloid deposition in brains of subjects with diabetes. Neuropathol Appl Neurobiol (2008) 1.16
Hippocampus and entorhinal cortex in frontotemporal dementia and Alzheimer's disease: a morphometric MRI study. Biol Psychiatry (2000) 1.16
Apolipoprotein E genotype and hippocampal asymmetry in Alzheimer's disease: a volumetric MRI study. J Neurol Neurosurg Psychiatry (2000) 1.16
Combined diffusion and perfusion MRI with correlation to single-photon emission CT in acute ischemic stroke. Ischemic penumbra predicts infarct growth. Stroke (1999) 1.15
SPECT and MRI analysis in Alzheimer's disease: relation to apolipoprotein E epsilon 4 allele. J Neurol Neurosurg Psychiatry (1996) 1.15
Polymorphisms in the CYP19 gene confer increased risk for Alzheimer disease. Neurology (2004) 1.15
Severity of hippocampal atrophy correlates with the prolongation of MRI T2 relaxation time in temporal lobe epilepsy but not in Alzheimer's disease. Neurology (1996) 1.14
Genome-wide linkage disequilibrium mapping of late-onset Alzheimer's disease in Finland. Neurology (2001) 1.14
Secular trends in the rates and seasonality of violent and nonviolent suicide occurrences in Finland during 1980-95. J Affect Disord (1998) 1.14
Plasma Abeta42 and Abeta40 as markers of cognitive change in follow-up: a prospective, longitudinal, population-based cohort study. J Neurol Neurosurg Psychiatry (2010) 1.13
Loss of synaptophysin-like immunoreactivity in the hippocampal formation is an early phenomenon in Alzheimer's disease. Neuroscience (1995) 1.12
3-year study of donepezil therapy in Alzheimer's disease: effects of early and continuous therapy. Dement Geriatr Cogn Disord (2006) 1.12
Fat intake at midlife and risk of dementia and Alzheimer's disease: a population-based study. Dement Geriatr Cogn Disord (2006) 1.11
Prevalence of ageing-associated cognitive decline in an elderly population. Age Ageing (1996) 1.10
MR imaging in pelvic inflammatory disease: comparison with laparoscopy and US. Radiology (1999) 1.10
Psychopathy and the posterior hippocampus. Behav Brain Res (2001) 1.09
How complex interactions of ischemic brain infarcts, white matter lesions, and atrophy relate to poststroke dementia. Arch Neurol (2000) 1.09
Relationship between apoE genotype and CSF beta-amyloid (1-42) and tau in patients with probable and definite Alzheimer's disease. Neurobiol Aging (2000) 1.09
Survey of protocols for the manual segmentation of the hippocampus: preparatory steps towards a joint EADC-ADNI harmonized protocol. J Alzheimers Dis (2011) 1.08
Neurotransmitter changes in Alzheimer's disease: implications to diagnostics and therapy. J Neurosci Res (1990) 1.08
Remodeling of neuronal circuitries in human temporal lobe epilepsy: increased expression of highly polysialylated neural cell adhesion molecule in the hippocampus and the entorhinal cortex. Ann Neurol (1998) 1.08
Harmonized diagnostic criteria for Alzheimer's disease: recommendations. J Intern Med (2014) 1.07
Apathy and cortical atrophy in Alzheimer's disease. Int J Geriatr Psychiatry (2010) 1.07
Bone tunnel enlargement after anterior cruciate ligament reconstruction with the hamstring autograft and endobutton fixation technique. A clinical, radiographic and magnetic resonance imaging study with 2 years follow-up. Knee Surg Sports Traumatol Arthrosc (1999) 1.06
Working memory of identification of emotional vocal expressions: an fMRI study. Neuroimage (2001) 1.06
Serum total cholesterol, statins and cognition in non-demented elderly. Neurobiol Aging (2007) 1.06
Recall and recognition memory in patients with Alzheimer's and Parkinson's diseases. Ann Neurol (1988) 1.06
Combined perfusion- and diffusion-weighted MR imaging in acute ischemic stroke during the 1st week: a longitudinal study. Radiology (2000) 1.05
Cerebral hemodynamics in a healthy population measured by dynamic susceptibility contrast MR imaging. Acta Radiol (2003) 1.05
Safety of lumbar puncture procedures in patients with Alzheimer's disease. Curr Alzheimer Res (2009) 1.05
Diagnosis of Alzheimer's disease: MRI of the hippocampus vs delayed recall. Neuropsychologia (2000) 1.05
Major decrease in the volume of the entorhinal cortex in patients with Alzheimer's disease carrying the apolipoprotein E epsilon4 allele. J Neurol Neurosurg Psychiatry (1998) 1.05
Interaction between genetic and environmental risk factors for Alzheimer's disease: a reanalysis of case-control studies. Genet Epidemiol (1994) 1.05
Computed tomography findings in senile dementia and normal aging. J Neurol Neurosurg Psychiatry (1982) 1.04